Merit Financial Group, LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q2 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
Merit Financial Group, LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q2 2024$276,936
-30.9%
43,819
+0.0%
0.01%
-40.0%
Q1 2024$400,880
+82.3%
43,812
+0.0%
0.01%
+42.9%
Q4 2023$219,876
+197.0%
43,8000.0%0.01%
+250.0%
Q3 2023$74,022
+11.9%
43,800
+84.0%
0.00%0.0%
Q2 2023$66,164
+52.7%
23,8000.0%0.00%0.0%
Q1 2023$43,31623,8000.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$3,857,0000.50%
ORACLE INVESTMENT MANAGEMENT INC 400,013$2,244,0000.44%
HARBOURVEST PARTNERS LLC 335,709$1,883,0000.38%
Winning Points Advisors, LLC 60,126$339,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$541,0000.19%
SHEETS SMITH WEALTH MANAGEMENT 203,876$1,144,0000.16%
Delphia (USA) Inc. 25,504$143,0000.11%
Clearwater Capital Advisors, LLC 147,891$830,0000.10%
Corton Capital Inc. 36,843$207,0000.09%
Virtus ETF Advisers LLC 27,343$153,0000.07%
View complete list of IMMUNITYBIO INC shareholders